Uterine carcinosarcoma with p53-positive intraepithelial component

Histopathology

Volumn 59, Issue 6, 2011, Pages 1277-1278

  Keeling, Laura ^a   Taraporewalla, Danesh ^a   Perunovic, Branko ^a   Smith, John H F ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER MORPHOLOGY; CARCINOSARCOMA; ENDOMETRIAL INTRAEPITHELIAL CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LETTER; MIXED MULLERIAN TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CARCINOSARCOMA; UTERUS CARCINOMA;

CARCINOSARCOMA; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 84855917447     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03996.x     Document Type: Letter

References (6)

1. Taylor NP, Zighelboim I, Huettner PC et al. DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis. Mod. Pathol. 2006; 19; 1333-1338.
2. McCluggage WG. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J. Clin. Pathol. 2002; 55; 321-325.
3. Amant F, Cadron I, Fuso L et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol. Oncol. 2005; 98; 274-280.
4. Catasus L, Gallardo A, Prat J. Molecular genetics of endometrial carcinoma. Diagn. Histopathol. 2009; 15; 554-563.
5. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum. Pathol. 1995; 26; 1268-1274.
6. Ambros RA, Sherman ME, Zahn CM et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum. Pathol. 1995; 26; 1260-1267.